Skip to content
ContentLora

    Tip: press / anywhere to search.

    technology

    Precision fermentation

    Also known as precision fermentation proteins, animal-free protein fermentation

    Precision fermentation grows an engineered microbe to make one defined protein, such as ovalbumin with the same sequence as chicken egg white, rather than a bulk commodity.[1] In the United States the approval route runs through GRAS notification, and in 2026 the binding constraint is reported to be a shortage of pilot- and demonstration-scale fermentation capacity.[2][3]

    Editor reviewedUpdated Synthetic biologyLife sciencesScience
    Key facts

    What it is

    Precision fermentation is the production of a single, defined molecule, usually a protein, by an engineered microorganism in a fermenter. The distinction from traditional fermentation is the target: not beer or ethanol but one specified product whose sequence is chosen in advance. Onego Bio’s Bioalbumen is a representative case, an ovalbumin with the same amino acid sequence as the protein in chicken egg white, secreted by the filamentous fungus Trichoderma reesei.[1]

    Host choice is conservative on purpose. T. reesei has long been used in the industrial enzyme business, so the strain handling, media and downstream recovery are already understood at scale.[1]

    The regulatory gate

    In the United States, food proteins made this way generally reach the market through a GRAS notification to the Food and Drug Administration. Onego Bio announced on 24 September 2025 that the agency had issued a “no questions” letter on the GRAS status of Bioalbumen, filed as GRAS Notice GRN 1249.[2] A no-questions letter is not an affirmative approval; it records that the agency does not object to the notifier’s own safety conclusion.

    Capacity, not science, is the bottleneck

    Several independent lines of evidence point the same way. The United States is reported to be severely short of pilot- and demonstration-scale precision fermentation equipment.[3] BioMADE says the gap drives American companies to use overseas facilities, taking innovation with them and risking loss of intellectual property.[4] And the public response has been to build shared tankage: a $132 million, 122,000-square-foot demonstration facility in Maple Grove, Minnesota with two 25,000-litre fermenters, finalised in April 2025.[5]

    Scale ladders matter here. BioMADE’s Hayward, California pilot plant offers tanks of up to 4,000 litres, and its Iowa site near Ames has 5,000 and 10,000-litre fermenters: the intermediate steps a company needs before committing to commercial volumes.[6][7]

    How it compares with cell-free routes

    Cell-free expression makes protein without any organism, but reported yields of about 4 milligrams per millilitre place it in a different category from tank fermentation for commodity proteins.[8][9] For food ingredients, where cost per kilogram decides, live hosts in large vessels remain the route.[1]

    Who is paying for the tanks

    The pilot capacity behind precision fermentation is largely publicly funded. BioMADE is a Department of Defense-sponsored Bioindustrial Manufacturing Innovation Institute whose stated mission is to enable domestic bioindustrial manufacturing at all scales, and it said in November 2025 that its network had passed 325 members across 40 states.[10][11] Its Hayward project is worth at least $80 million with Department of Defense funding, and the Iowa site is a $40 million project splitting costs between BioMADE, Iowa State University and a state infrastructure programme.[6][7] BioMADE describes the network as critically needed pilot-scale capacity for moving products out of the laboratory into commercial and defence markets.[12]

    Research money follows the same route. On 29 April 2026 BioMADE said 14 new projects represented over $21 million across 23 member organisations, with federal funding from the US Department of War and the National Science Foundation alongside non-federal cost share.[13] For a food or materials company, that matters because the alternative to shared tankage is building its own or going abroad, which BioMADE says risks taking American innovation and intellectual property with it.[4]

    What to watch

    Three things: further GRAS outcomes, because each one sets precedent for a protein class;[2] whether the new pilot plants open on schedule, since BioMADE aimed to open Hayward to customers in early 2026 and its Iowa date has moved between 2027 and early 2028;[6][14] and whether federal funding continues at the levels seen so far, which included about $87 million at BioMADE’s inception and $450 million in 2023.[15]

    Questions readers ask

    What is precision fermentation?

    Growing an engineered microbe so that it secretes one specific protein. Onego Bio's Bioalbumen is ovalbumin made in the filamentous fungus Trichoderma reesei.[1]

    Is fermented animal protein approved in the United States?

    Case by case. Onego Bio announced in September 2025 that the FDA had no questions about the GRAS status of its egg protein, filed as GRN 1249.[2]

    Is the protein the same as the animal version?

    For Bioalbumen the amino acid sequence is described as identical to the protein in chicken egg white.[1]

    What is holding the sector back?

    Capacity. The United States is reported to be severely short of pilot- and demonstration-scale precision fermentation equipment, which is why federal money is going into shared plants.[3][4]

    Sources

    Each numbered claim is a statement we checked against the sources listed with it. Status shows how well established it is.

    1. [1]

      Onego Bio's Bioalbumen is ovalbumin with the same amino acid sequence as chicken egg white protein, made by precision fermentation in the filamentous fungus Trichoderma reesei. confirmedas of 2025-09-24

    2. [2]

      On 24 September 2025 Onego Bio said the US Food and Drug Administration had issued a "no questions" letter on the GRAS status of its Bioalbumen egg protein, filed as GRAS Notice GRN 1249. confirmedas of 2025-09-24

    3. [3]

      The United States is reported to be severely short of pilot- and demonstration-scale equipment for precision fermentation, which is the stated reason for federal investment in bioindustrial pilot plants. reportedas of 2026-05-11

    4. [4]

      BioMADE says the shortage of pilot- to demonstration-scale capacity forces American companies to use facilities overseas, taking innovation with them and risking loss of intellectual property. confirmedas of 2025-04-29

    5. [5]

      On 29 April 2025 BioMADE finalised a $132 million investment, funded by the US Department of Defense and Minnesota's economic development department, in a 122,000-square-foot demonstration-scale biomanufacturing facility in Maple Grove, Minnesota with two 25,000-litre industrial fermenters. confirmedas of 2025-04-29

    6. [6]

      BioMADE's California pilot plant in Hayward is a nearly 25,000-square-foot multi-user facility with aerated stirred tanks of up to 4,000 litres, in a project worth at least $80 million funded by the US Department of Defense; BioMADE said in April 2025 that it aimed to open it to customers in early 2026. confirmedas of 2025-04-30

    7. [7]

      BioMADE's Iowa pilot plant, built near Ames with Iowa State University, is a 15,000-square-foot multi-user site with 5,000 and 10,000-litre industrial fermenters, in a $40 million project to which BioMADE committed at least $20 million, matched by up to $10 million from the university and $10 million from a state infrastructure programme. confirmedas of 2025-11-14

    8. [8]

      The all-E. coli TXTL toolbox 3.0 reported protein synthesis of 4 milligrams per millilitre in batch reactions and more than 8 milligrams per millilitre inside synthetic cell compartments. confirmedas of 2021-08-04

    9. [9]

      Cell-free transcription-translation (TXTL) systems express genes in a tube using extracted cellular machinery, and are used to test genetic regulatory elements and circuits without living cells. confirmedas of 2021-08-04

    10. [10]

      BioMADE is a Manufacturing USA institute for bioindustrial manufacturing that works to build national infrastructure for taking biotechnology from laboratory scale to commercial production. confirmedas of 2025-04-29

    11. [11]

      BioMADE said in November 2025 that its network had passed 325 members across 40 states, and that it was catalysed by the US Department of Defense in October 2020 as a member of Manufacturing USA. confirmedas of 2025-11-14

    12. [12]

      BioMADE describes its Pilot Plant Network as critically needed pilot-scale bioindustrial manufacturing facilities intended to move products out of the laboratory and into commercial and defence markets. confirmedas of 2026-04-29

    13. [13]

      BioMADE said on 29 April 2026 that 14 new projects represented a shared investment of over $21 million across 23 member organisations, with federal money from the US Department of War and the National Science Foundation alongside non-federal cost share. confirmedas of 2026-04-29

    14. [14]

      BioMADE's stated opening date for the Iowa pilot plant has moved. An August 2025 release said the site was set to open in early 2028, while the November 2025 groundbreaking release said it was scheduled to open in 2027. disputedas of 2025-11-14

    15. [15]

      The US Department of Defense gave BioMADE about $87 million at its inception and directed a further $450 million to it in 2023. reportedas of 2026-05-11

    16. [16]

      Ansa Biotechnologies announced commercial availability of clonal DNA constructs up to 50 kilobases made on its enzymatic DNA synthesis platform, roughly 100 times longer than its first product. reportedas of 2025-10-01

    Revision history (2)
    1. Page created.
    2. Refresh: re-sourced the pilot-plant scale ladder to BioMADE's own releases, added the Iowa date conflict, the April 2026 project awards and the Trichoderma reesei provenance.

    Created Oct 10, 2026. Last reviewed by an editor on Oct 10, 2026. Next scheduled review: Jan 10, 2027.

    Cite this page

    "Precision fermentation." ContentLora, updated Oct 10, 2026. https://contentlora.com/wiki/precision-fermentation

    Spotted an error? Suggest a correction or emailcorrections@contentlora.com.

    Keep exploring

    Connections
    BioMADE Depends on capacity fromCell-free protein s… Alternative toEnzymatic DNA synth… Strains engineered with
    ☰ Contents